发明名称 |
<i>Salmonella enterica </i>presenting <i>C. jejuni </i>N-glycan or derivatives thereof |
摘要 |
The present invention relates to Salmonella enterica comprising at least one pgl operon of Campylobacter jejuni or a functional derivative thereof and presenting at least one N-glycan of Campylobacter jejuni or N-glycan derivative thereof on its cell surface. In addition, it is directed to medical uses and pharmaceutical compositions thereof as well as methods for treating and/or preventing Campylobacter and optionally Salmonella infections and methods for producing these Salmonella strains. |
申请公布号 |
US9309493(B2) |
申请公布日期 |
2016.04.12 |
申请号 |
US201013254232 |
申请日期 |
2010.03.25 |
申请人 |
Eidgenoessische Technische Hochschule Zurich |
发明人 |
Ilg Karin;Aebi Markus;Ahuja Umesh;Amber Saba;Schwarz Flavio |
分类号 |
C12N1/20;C12N1/36;A61K39/112;A61K39/02;A61K39/00 |
主分类号 |
C12N1/20 |
代理机构 |
Juneau & Mitchell |
代理人 |
Juneau & Mitchell |
主权项 |
1. Salmonella enterica, comprising at least one pgl operon of Campylobacter jejuni and further comprising at least one N-glycan of Campylobacter jejuni on its cell surface, wherein one or more genes for bacillosamine biosynthesis are inactivated by mutation or partial or complete deletion. |
地址 |
Zurich CH |